Heat Biologics (HTBX) Announces $1.5M Loan Paydown Following Warrant Exercise
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Heat Biologics, Inc. (“Heat”) (Nasdaq: HTBX) announced that it has paid down $1.5 million on its commercial loan following the recent exercise of warrants, which have generated $2.8 million in cash proceeds last quarter.
“We continue to strengthen our balance sheet and carefully manage expenses while pursuing an aggressive clinical program that will generate four important data readouts this quarter,” commented Jeff Wolf, Heat’s Founder and CEO.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XL Group (XL) Announces Senior Management Changes Related to Realigned P&C Operating Model
- Teleflex's (TFX) Arrow VPS Rhythm System Cleared in Europe
- Agilysys, Inc. (AGYS) Plans CEO Search; CFO Seebeck Resigns
Create E-mail Alert Related CategoriesCorporate News, Management Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!